Selecting the Right Treatment for Your Patient: Balancing the Needs for Cytogenetic Testing With the Urgency of Treatment Initiation

Dr Erin Hurst and Dr Priyanka Mehta discuss striking the right balance between using cytogenetic testing to inform treatment decisions in patients with acute myeloid leukaemia and initiating treatment as soon as possible, and how to utilise the time between cytogenetic test and results effectively.

Prescribing information can be found at the top of this page. Adverse event reporting is available at the bottom of this page.

Topics: Cytogenetics

ADVERSE EVENTS REPORTING

Adverse events should be reported. Reporting forms and information for the UK can be found at https://yellowcard.mhra.gov.uk/

For Ireland, reporting forms and information can be found at: www.hpra.ie

Adverse events should also be reported to Jazz Pharmaceuticals at AEreporting@jazzpharma.com

UK-VYX-2100032 | March 2021